SCHEMBL25528612

SCHEMBL25528612

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(Cc3ccc(F)cc3)c2)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 8/20 0.53
THRB P10828 8/20 0.53
HSP90AA1 P07900 2/20 0.40
HSP90B1 P14625 1/20 0.40
MAOB P27338 3/20 0.39
MAOA P21397 1/20 0.39
MEN1 O00255 2/20 0.38
PKM P14618 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC7A5 Q01650 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528683 0.94 THRB (0.47) THRATHRBHSP90AA1HSP90B1MAOB
SCHEMBL25528702 0.91 THRA (0.53) THRATHRBHSP90AA1HSP90B1MAOB
SCHEMBL25528657 0.91 THRA (0.55) THRATHRBHSP90AA1MAOBMAOA
SCHEMBL25528655 0.90 THRA (0.50) THRATHRBMAOBMAOAALDH1A1
SCHEMBL23003632 0.90 THRB (0.62) THRATHRBHSP90AA1HSP90B1MEN1
SCHEMBL25528658 0.90 THRB (0.54) THRATHRBHSP90AA1MAOBMEN1
SCHEMBL25528726 0.90 THRA (0.56) THRATHRBHSP90AA1MEN1KMT2A
SCHEMBL25528656 0.89 THRA (0.49) THRATHRBMAOBMAOAMEN1
SCHEMBL23003765 0.89 THRA (0.51) THRATHRBHSP90AA1HSP90B1MEN1
SCHEMBL23003773 0.89 THRA (0.51) THRATHRBHSP90AA1HSP90B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885HSP90AA1 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.